Vax At Home.
We’re meeting Baltimore
where Baltimore’s at.
Mobile vaccination teams are going door-to-door to meet you, a service for those who can't leave their homes.
Appointment required.
Sign up at https://t.co/z8XaXz6Nma or by calling 443-984-8650.
Thrilled to share our inaugural blog post authored by Daniele Merico, Head of Target Identification, and featured on our website. Learn more about our #AI Workbench and our approach to programming RNA therapeutics. https://t.co/I4cqDqLKFq #genomics#deeplearning#biotech
We're thrilled to release a manuscript on rare variant association testing on the exomes of 300k individuals in the UK Biobank https://t.co/Kgyc9Vk7Nq and a browser of the results: https://t.co/c8PJajiHK3
Looking for a postdoc at @CGM_MGH@broadinstitute? Interested in the genetics of human complex disorders? We're recruiting!
Expertise in stat gen, comp bio, pop gen or epigenomics.
More: https://t.co/yEpW34sUrX
Apply: https://t.co/PXR125kPf0
Please RT!
#sciencejobs#ASHGtrainee
A large-scale genomics resource of East Asian ancestry made available by Taiwan Biobank. A joint project with @ChiayenChen @DrYenFengLin @getian107@AnnejaneF@dalygene and many others!
Excited to say that the mitochondrial DNA copy number GWAS that I worked on with @RyanLongchamps in @dan_arking's lab is now up on BioRxiv! https://t.co/P7FJ7b1ju4
One-time treatment, permanent lowering of LDL, really?
Yes!
Today, we @VerveTx announce durable lowering of blood
PCKS9 protein (⬇️89%)
&
LDL-C (⬇️61%)
out to 6+ months after a one-time gene editing treatment in non-human primates
#JPM2021
https://t.co/THsAuUUaLv
#ASHG2020 Check our Reviewers' Choice Award Poster.
It is on 036 Poster Talks today at 5:30pm ET
(We are almost there for preprint on BioRxiv.)
Many thanks to my supervisor @hailianghuang@getian107
Besides the chat function, you are also welcome to reply/RT/DM for Q&A
Our review on mitochondrial DNA copy number and its emerging role in health and disease is now available online @ Mitochondrion #ArkingLab https://t.co/5w0dZUibhQ @RyanLongchamps @dan_arking
I was asked to write a perspective on the potential use of CRISPR for genetic diseases/disorders. What came was very personal. It is not proscriptive. It is a perspective that I have now that I could not have had before
https://t.co/hcO8Vd6A6d
After being told of BRCA1 mutation,
up to 50% women opt for prophylactic mastectomy
Should this be so?
For "monogenic" forms breast ca, colorectal ca, & heart attack, we find polygenic background powerfully modifies risk
New on @medrxivpreprint
https://t.co/JKteEV5MYu
When you run a genomics core facility in a developing country your No.1 fear is "will there be enough users in the region to keep up with technology updates and justify the huge investment on equipment?" Here's an example from Mexico @langebiomx @labsergen@cinvestav 1/6
The call to increase GWAS sample sizes in non-European ancestry pop’ns has gotten so much needed attention that I sometimes worry we may be missing opportunities to use current PRS to benefit these pop’ns. For instance… 1/4
👩🏫Want a tenure track data science teaching position?
🌞Come join me! Teach awesome students and work w/ the best colleagues in San Diego, where you can tweet from your backyard w/o a jacket mid-Fall!
💻Apply here: https://t.co/gIRyXoTHHz
The bioRxiv team has done far, far more for science than most scientists will ever do. Huge congratulations to @cshperspectives and his crew - transforming biology one preprint at a time.